HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Trimetazidine hydrochloride as a new treatment for patients with peripheral vascular disease--an exploratory trial.

AbstractOBJECTIVE:
To evaluate the therapeutic effect of trimetazidine hydrochloride in peripheral vascular disease patients who had Rutherford classification grade 2-3.
PATIENTS AND METHODS:
72 patients with Rutherford classification grade 2-3 in peripheral vascular were recruited successfully, they were randomly assigned to control group (35 cases) and trimetazidine group (37 cases), patients in control group received conventional treatment and trimetazidine group received conventional treatment plus trimetazidine hydrochloride for 6 months. Their ankle brachial index (ABI), maximum walking distance, pain onset time and the maximum walking time were compared before and after the treatment.
RESULTS:
After 6 months' treatment, the ABI, maximum walking distance, pain onset time and the maximum walking time in two groups were both improved of when compared with before treatment (p < 0.05). The maximum walking distance, pain onset time and the maximum walking time in trimetazidine group were improved better than control (p < 0.05) while no evident improvement in ABI between the 2 groups (p > 0.05).
CONCLUSIONS:
Conventional therapy plus trimetazidine hydrochloride could significantly improve the clinical symptoms of patients with Rutherford classification Grade 2-3 in peripheral vascular.
AuthorsY-S Chu, D-X Li, M Zhang, T-M Jiang
JournalEuropean review for medical and pharmacological sciences (Eur Rev Med Pharmacol Sci) Vol. 20 Issue 1 Pg. 188-93 ( 2016) ISSN: 2284-0729 [Electronic] Italy
PMID26813473 (Publication Type: Journal Article, Randomized Controlled Trial)
Chemical References
  • Vasodilator Agents
  • Trimetazidine
Topics
  • Aged
  • Ankle Brachial Index
  • Female
  • Humans
  • Intermittent Claudication (drug therapy, etiology)
  • Male
  • Middle Aged
  • Peripheral Vascular Diseases (complications, diagnosis, drug therapy)
  • Trimetazidine (therapeutic use)
  • Vasodilator Agents (therapeutic use)
  • Walking

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: